Singapore HSA registration DE0006725
BAUSCH & LOMB AMVISC PLUS INJECTION 16 mg/ml
Singapore·CLASS D·Bausch & Lomb Incorporated·Registered May 16, 2011Device classification
- Device Class
- CLASS D
- Medical Speciality Area
- Ophthalmology
Registration information
- Registration Number
- DE0006725
- Registration Date
- May 16, 2011
- Change Notification Approval Date
- October 29, 2024
- Retention Due Date
- January 15, 2026
Product description
For use as a surgical aid in ophthalmic anterior and posterior segment procedures.
Product Owner
- Short Name
- Bausch & Lomb
- Address
- 1400 North Goodman Street, Rochester, NY 14609, UNITED STATES
Registrant
- Address
- 3 HARBOURFRONT PLACE, HARBOURFRONT TOWER TWO, #09-04, SINGAPORE 099254
Importer
- Address
- 3 HARBOURFRONT PLACE, HARBOURFRONT TOWER TWO, #09-04, SINGAPORE 099254
Model information
- Model Name(s)
- AMVISC PLUS INJECTION 16 mg/ml (1 x 0.8ml)
- Model Identifier(s)
- 60081L
About this record
Access comprehensive regulatory information for BAUSCH & LOMB AMVISC PLUS INJECTION 16 mg/ml in the Singapore medical device market through Pure Global AI's free database. This CLASS D medical device is registered under HSA registration number DE0006725 and owned by Bausch & Lomb Incorporated. The device was registered on May 16, 2011.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
Free DatabasePowered by Pure Global AIHSA Official DataCLASS D